Healthcare Latest news, Medical Technology Updated News
The British-Swedish pharma giant AstraZeneca (AZ) has decided to sublicense its global rights to Movantik (naloxegol) to RedHill Biopharma. However, AZ has said that it will continue to manufacture and supply the chronic non-cancer pain drug to RedHill during a…
AstraZeneca has confirmed that budesonide / glycopyrronium / formoterol fumarate has been approved for chronic obstructive pulmonary disease (COPD) rehabilitation treatment in China. This is the National Medical Products Administration’s first certification for a triple-combination therapy in a pressurized metered-dose…
The primary yearly Pharmaceutical Invention Index, discharged by IDEA Pharma today, sees AstraZeneca top the business for the curiosity and broadness of its pipeline. Discharged without precedent for 2019, at the Pharma Innovation Summit in Boca Raton, FL, the Pharmaceutical…
Japan’s Shionogi and Co Ltd <4507.T> has played safe when selling its medications in the United States and different abroad markets – depending on greater accomplices to advance its items and evading the expense of keeping up an enormous deals…
According to the results of phase III clinical trial, by the addition of Imfinzi to the standard first-line chemotherapy resulted in the clinically meaningful extension in the overall survival rate of the patients who have advanced small cell lung cancer…